The Potential of Medicinal Plants in Antifungal Drug Development: Mechanisms, Synergies, and Future Directions

Abstract

Fungal infections pose a significant threat to global health, leading to considerable morbidity and mortality in humans, animals, and plants. The rise of drug-resistant fungal strains, coupled with the limitations of current antifungal therapies, such as toxicity and the potential for resistance, has prompted the exploration of alternative treatments. Medicinal plants, with their bioactive phytochemicals, have emerged as promising sources of antifungal agents. These compounds, which include phenols, alkaloids, terpenoids, and phytosterols, exhibit diverse mechanisms of action, such as disruption of fungal cell membranes, inhibition of cell wall synthesis, and induction of mitochondrial dysfunction. This review discusses the effect of various fungal pathogens, such as Candida albicans, Aspergillus fumigatus, and Fusarium species, highlighting their virulence factors and the diseases they cause. It also examines the antifungal properties of medicinal plants, focusing on specific species and their bioactive compounds targeting fungal cells. This study explores the mechanisms through which phytochemicals such as alkaloids, flavonoids, and saponins inhibit fungal growth and the potential for synergistic effects when combined with conventional antifungals. While acknowledging the importance of safety, standardization, and toxicity evaluations, the review also delves into the role of computational drug-discovery methods, such as molecular docking and artificial intelligenceassisted screening, in identifying potential antifungal candidates. Despite challenges such as the variability in plant composition and the need for further clinical data, this review emphasizes the significant potential of medicinal plants in addressing drug-resistant fungal infections and outlines the directions for future research, including biotechnology, nanotechnology, and the exploration of understudied plant species.